Investors > News Releases
Feb 22, 2019
Vectra® Study Published in the Journal Current Medical Research & Opinion
Pipeline
Feb 15, 2019
Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer
Products
Feb 13, 2019
Myriad Genetics to Present at Multiple Upcoming Healthcare Conferences
Corporate
Feb 11, 2019
Myriad Announces Prequel™ Prenatal Screen with Expanded Aneuploidy Analysis for all 23 Chromosome Pairs
Pipeline
Feb 08, 2019
Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting
Pipeline
Feb 05, 2019
Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results
Financial
Jan 28, 2019
Myriad to Announce Fiscal Second-Quarter 2019 Financial Results on February 5, 2019
Corporate
Jan 04, 2019
GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
Products
Dec 31, 2018
Peter D. Meldrum (1947-2018)
Corporate
Dec 27, 2018
Myriad Genetics to Present at the 37th Annual J.P. Morgan Healthcare Conference
Corporate
Dec 26, 2018
Myriad Announces Publication of Vectra® Study in Journal Rheumatology
Products
Dec 19, 2018
BRACAnalysis CDx® Approved by U.S. Food and Drug Administration as Companion Diagnostic for AstraZeneca’s Lynparza® (olaparib) in Patients with Advanced-Stage, BRCA-Mutated Ovarian Cancer
Products
Dec 19, 2018
EndoPredict® Test Receives Positive NICE Recommendation for Patients with Early Breast Cancer
Products
Dec 07, 2018
Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer
Products
Dec 07, 2018
Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium
Products